We are live on
!
Find out more
NCM
Novare Capital Management Portfolio holdings
AUM
$1.41B
1-Year Est. Return
25.38%
This Fund
S&P 500
This Quarter
Est. Return
-12.6%
1 Year Est. Return
+25.38%
3 Year Est. Return
+76.47%
5 Year Est. Return
+92.66%
10 Year Est. Return
+281.33%
AUM
$810M
AUM Growth
-$128M
(-14%)
Cap. Flow
+$1.04M
Cap. Flow
% of AUM
0.13%
Top 10 Holdings %
Top 10 Hldgs %
28.71%
Holding
186
New
11
Increased
72
Reduced
59
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thor Industries
THO
|
+$7.65M |
| 2 |
Realty Income
O
|
+$5.91M |
| 3 |
Duke Energy
DUK
|
+$5.12M |
| 4 |
Merck
MRK
|
+$4.89M |
| 5 |
Vanguard Information Technology ETF
VGT
|
+$4.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$7.75M |
| 2 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$7.2M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$5.79M |
| 4 |
PayPal
PYPL
|
+$3.8M |
| 5 |
American Tower
AMT
|
+$3.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 12.09% |
| 3 | Consumer Discretionary | 9.62% |
| 4 | Industrials | 8.63% |
| 5 | Financials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Medtronic
MDT
$114B
| – | – |
-11,503
| Closed | -$1.28M |
|
177
MSC Industrial Direct
MSM
$6.85B
| – | – |
-2,725
| Closed | -$232K |
|
178
Micron Technology
MU
$992B
| – | – |
-2,725
| Closed | -$212K |
|
179
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
| – | – |
-2,500
| Closed | -$394K |
|
180
Targa Resources
TRGP
$56.9B
| – | – |
-3,000
| Closed | -$226K |
|
181
Union Pacific
UNP
$174B
| – | – |
-934
| Closed | -$255K |
|
182
Upstart Holdings
UPST
$2.96B
| – | – |
-2,000
| Closed | -$218K |
|
183
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$292M
| – | – |
-260
| Closed | -$875K |
|
184
Vertiv
VRT
$105B
| – | – |
-40,965
| Closed | -$574K |
|
185
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.22B
| – | – |
-4,045
| Closed | -$283K |
|
|
BSCM
186
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
| – | – |
-9,750
| Closed | -$207K |
|
Similar funds
EA
IAS
TWM
SCM
EWS
KC
FCP
CBA
Novare Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Novare Capital Management held 186 positions worth $810M, down 14% from $938M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Novare Capital Management's Q2 2022 filing shows 11 new, 72 increased, 59 reduced and 23 closed positions. Its largest new stake was Thor Industries: 98,575 shares worth $7.37M. The largest sale was Bristol-Myers Squibb, an estimated $7.75M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Novare Capital Management's largest Q2 2022 buy was Thor Industries: 98,575 shares worth $7.37M.
- Novare Capital Management added most to Realty Income in Q2 2022, an estimated $5.91M increase.
- Novare Capital Management's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $7.75M.
- Novare Capital Management fully exited Medtronic in Q2 2022, selling an estimated $1.28M.
- Novare Capital Management's ten largest holdings make up 29% of its $810M portfolio in Q2 2022.
- Novare Capital Management opened 11 new positions and closed 23 in Q2 2022.
- Novare Capital Management's portfolio value fell 14% quarter-over-quarter to $810M.
Based on Novare Capital Management's 13F filing for Q2 2022, filed 3 Aug 2022.